SE9703379D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9703379D0 SE9703379D0 SE9703379A SE9703379A SE9703379D0 SE 9703379 D0 SE9703379 D0 SE 9703379D0 SE 9703379 A SE9703379 A SE 9703379A SE 9703379 A SE9703379 A SE 9703379A SE 9703379 D0 SE9703379 D0 SE 9703379D0
- Authority
- SE
- Sweden
- Prior art keywords
- sub
- alkyl
- substituted
- intermediates
- cycloalkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- -1 piperazinyl-substituted indan Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Liquid Crystal Substances (AREA)
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703379A SE9703379D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
| EP98944379A EP1025094B1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
| SI9830708T SI1025094T1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
| AU91934/98A AU734583B2 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
| ES98944379T ES2224429T3 (es) | 1997-09-18 | 1998-09-09 | Derivados de indano sustituido. |
| PT98944379T PT1025094E (pt) | 1997-09-18 | 1998-09-09 | Derivados de indano substituidos |
| CA002303839A CA2303839A1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
| DE69825912T DE69825912T2 (de) | 1997-09-18 | 1998-09-09 | Substituierte indanderivate |
| PCT/SE1998/001605 WO1999014207A1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
| AT98944379T ATE274502T1 (de) | 1997-09-18 | 1998-09-09 | Substituierte indanderivate |
| JP2000511758A JP4020183B2 (ja) | 1997-09-18 | 1998-09-09 | 置換されたインダン誘導体 |
| US09/171,575 US6548498B1 (en) | 1997-09-18 | 1998-09-09 | Substituted indan derivatives |
| US10/339,477 US20030144291A1 (en) | 1997-09-18 | 2003-01-09 | Substituted indan derivatives |
| US10/807,918 US20050096326A1 (en) | 1997-09-18 | 2004-03-24 | Substituted indian derivatives |
| US11/543,250 US7439356B2 (en) | 1997-09-18 | 2006-10-03 | Substituted indan derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703379A SE9703379D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9703379D0 true SE9703379D0 (sv) | 1997-09-18 |
Family
ID=20408299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9703379A SE9703379D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US6548498B1 (sv) |
| EP (1) | EP1025094B1 (sv) |
| JP (1) | JP4020183B2 (sv) |
| AT (1) | ATE274502T1 (sv) |
| AU (1) | AU734583B2 (sv) |
| CA (1) | CA2303839A1 (sv) |
| DE (1) | DE69825912T2 (sv) |
| ES (1) | ES2224429T3 (sv) |
| PT (1) | PT1025094E (sv) |
| SE (1) | SE9703379D0 (sv) |
| WO (1) | WO1999014207A1 (sv) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9703379D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
| BR0206512A (pt) | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Composto, método de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de um composto, e, processo para preparar um composto. |
| CN1592745A (zh) | 2001-01-16 | 2005-03-09 | 阿斯特拉曾尼卡有限公司 | 治疗用苯并－γ－吡喃酮化合物 |
| JPWO2006088246A1 (ja) * | 2005-02-18 | 2008-07-10 | 武田薬品工業株式会社 | Ｇｐｒ３４受容体機能調節剤 |
| US8306918B2 (en) | 2005-10-11 | 2012-11-06 | Apple Inc. | Use of media storage structure with multiple pieces of content in a content-distribution system |
| US7592461B2 (en) | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| CN102176923A (zh) * | 2008-10-15 | 2011-09-07 | 日东电工株式会社 | 制备聚谷氨酸酯结合物的方法 |
| CN102666566A (zh) * | 2009-12-16 | 2012-09-12 | 日东电工株式会社 | 聚谷氨酸的受控合成 |
| GB201002563D0 (en) | 2010-02-15 | 2010-03-31 | Cambridge Entpr Ltd | Compounds |
| US9815768B2 (en) | 2014-02-28 | 2017-11-14 | Sumitomo Chemical Company, Limited | Method for producing 2-(halogenomethyl)-3-methylnitrobenzene |
| WO2016092547A1 (en) * | 2014-12-09 | 2016-06-16 | Ezekiel Golan | Alcoholic beverage substitutes |
| CN112500301B (zh) * | 2014-12-09 | 2024-02-13 | 以西结·戈兰 | 放纵行为调节剂 |
| WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2918282A (en) * | 1958-02-07 | 1959-12-22 | Waterval William | Health exercising devices |
| DE69427289T2 (de) | 1993-03-16 | 2001-09-06 | Pfizer Inc., New York | Naphtalinderivate |
| US5877218A (en) * | 1994-01-10 | 1999-03-02 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| SE9703379D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| WO2001053260A1 (en) * | 2000-01-18 | 2001-07-26 | Novartis Ag | Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
-
1997
- 1997-09-18 SE SE9703379A patent/SE9703379D0/sv unknown
-
1998
- 1998-09-09 JP JP2000511758A patent/JP4020183B2/ja not_active Expired - Fee Related
- 1998-09-09 WO PCT/SE1998/001605 patent/WO1999014207A1/en not_active Ceased
- 1998-09-09 US US09/171,575 patent/US6548498B1/en not_active Expired - Fee Related
- 1998-09-09 AU AU91934/98A patent/AU734583B2/en not_active Ceased
- 1998-09-09 EP EP98944379A patent/EP1025094B1/en not_active Expired - Lifetime
- 1998-09-09 PT PT98944379T patent/PT1025094E/pt unknown
- 1998-09-09 DE DE69825912T patent/DE69825912T2/de not_active Expired - Fee Related
- 1998-09-09 ES ES98944379T patent/ES2224429T3/es not_active Expired - Lifetime
- 1998-09-09 CA CA002303839A patent/CA2303839A1/en not_active Abandoned
- 1998-09-09 AT AT98944379T patent/ATE274502T1/de not_active IP Right Cessation
-
2003
- 2003-01-09 US US10/339,477 patent/US20030144291A1/en not_active Abandoned
-
2004
- 2004-03-24 US US10/807,918 patent/US20050096326A1/en not_active Abandoned
-
2006
- 2006-10-03 US US11/543,250 patent/US7439356B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69825912T2 (de) | 2005-09-01 |
| JP2001516752A (ja) | 2001-10-02 |
| US7439356B2 (en) | 2008-10-21 |
| AU734583B2 (en) | 2001-06-14 |
| DE69825912D1 (de) | 2004-09-30 |
| US6548498B1 (en) | 2003-04-15 |
| US20030144291A1 (en) | 2003-07-31 |
| PT1025094E (pt) | 2004-12-31 |
| JP4020183B2 (ja) | 2007-12-12 |
| EP1025094B1 (en) | 2004-08-25 |
| US20050096326A1 (en) | 2005-05-05 |
| AU9193498A (en) | 1999-04-05 |
| ES2224429T3 (es) | 2005-03-01 |
| EP1025094A1 (en) | 2000-08-09 |
| WO1999014207A1 (en) | 1999-03-25 |
| US20070149545A1 (en) | 2007-06-28 |
| CA2303839A1 (en) | 1999-03-25 |
| ATE274502T1 (de) | 2004-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9703379D0 (sv) | New compounds | |
| LU91196I2 (fr) | Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO). | |
| DE69528000D1 (de) | Zwischenprodukte zur Hertellung von Oxazolidindion- und Thiazolidindionderivate | |
| CY1107679T1 (el) | Παραγωγα οξαζολυλ-αρυλ προπιονικου οξεος και χρηση αυτων σαν αγωνιστες ppar | |
| TR200000736T2 (tr) | İkame edilmiş kroman türevleri. | |
| DE3772135D1 (de) | Phenolische korrosionsinhibitoren fuer anstrichstoffe. | |
| ATE14880T1 (de) | Cephalosporinverbindungen und ihre herstellung. | |
| DE69434198D1 (de) | Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten | |
| SE8000920L (sv) | 4-(naftylmetyl)piperidinderivat | |
| ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
| SE8003821L (sv) | Nya 3-aminovinylcefalosporiner och forfarande for framstellning derav | |
| NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav | |
| EP1535920A4 (en) | PROCESS FOR PREPARING 1,3-BENZODIOXOL-2-SPIRO-CYCLOALKANE DERIVATIVES | |
| YU310580A (en) | Process for obtaining new benzothiazole derivatives | |
| DE60003140D1 (de) | Kosmetische photoschutzzusammenstellungen enthaltende Aminoamidine Derivate und Verwendungen | |
| ES426135A1 (es) | Procedimiento de preparacion de esteres de aril-piperazino-alcanoles. | |
| SE8405430L (sv) | 7-acylindolforeningar, lempade som mellanprodukter vid synteser av 7-acylindolin-2-oner | |
| DE69002340D1 (de) | Pyrimidin-derivate, 2-(4-(alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl) mit serotoninergischer wirkung. | |
| SE8207394D0 (sv) | Organiska foreningar, deras framstellning och anvendning | |
| AU532634B2 (en) | Thiazolyl derivatives | |
| JPS646271A (en) | Carbostyril derivative | |
| HU912140D0 (en) | Fungicide preparations containing benzyl-ketones and process for the production of the active agents | |
| DK0555481T3 (da) | Tri(C1-C6-alkoxy)benzenderivat. | |
| FI871984A0 (fi) | 3-aminodihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| DK83183A (da) | N-hetero-cyclyl-4-piperidinaminer |